Armata Pharmaceuticals Set to Engage at Global Investment Conference

Author: Logan Wright Updated: 09-04-2025 07:12 AM

Armata Pharmaceuticals Joins H.C. Wainwright Global Investment Conference

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) is excited to announce its participation in the H.C. Wainwright 27th Annual Global Investment Conference. This important gathering is taking place in New York and is expected to attract a wide audience of investors, stakeholders, and industry experts.

Corporate Presentation Details

Deborah Birx, M.D., serves as the Chief Executive Officer of Armata and will lead the corporate presentation scheduled for September 10. Attendees can expect insights into Armata's latest developments in bacteriophage therapeutics, a pivotal area of focus for the company. Armata is at the forefront of tackling antibiotic-resistant infections through innovative technology.

Innovative Bacteriophage Therapeutics

At the heart of Armata's mission is the commitment to the development of high-purity, pathogen-specific bacteriophage therapeutics. These novel therapeutics aim to address the growing crisis of antibiotic-resistant infections effectively.

Pioneering Research and Development

Armata's research targets various challenging bacterial pathogens, including Pseudomonas aeruginosa and Staphylococcus aureus. Through rigorous clinical development, the company has been advancing a promising pipeline of both natural and synthetic phage candidates, demonstrating significant potential in revolutionizing infection management.

Engagement Opportunities at the Conference

During the conference, participants will have the chance to engage with Armata's representatives and learn more about the company’s innovative solutions. Those interested in one-on-one meetings can reach out to the H.C. Wainwright team to schedule discussions.

About Armata Pharmaceuticals

Armata Pharmaceuticals has established itself as a notable player in the biotechnology arena. With an unwavering dedication to tackling some of the toughest bacterial infections through phage therapy, the company leverages cutting-edge manufacturing practices to facilitate the development of its products. This includes adhering to current Good Manufacturing Practices throughout the research, development, and potential commercialization phases.

Contact Information

For Media Inquiries:

Pierre Kyme
310-594-7035

Investor Relations Contact:

Joyce Allaire
LifeSci Advisors, LLC
212-915-2569

Frequently Asked Questions

What is the purpose of the H.C. Wainwright conference?

The H.C. Wainwright conference brings together investors and companies to discuss upcoming innovations and strategies in the biotech industry.

Who is presenting for Armata Pharmaceuticals?

Deborah Birx, M.D., the Chief Executive Officer of Armata Pharmaceuticals, will lead the presentation at the conference.

What are bacteriophage therapeutics?

Bacteriophage therapeutics involve the use of viruses that specifically target and destroy bacterial pathogens, providing an innovative approach to treat infections.

What pathogens does Armata focus on?

Armata Pharmaceuticals concentrates its efforts on serious bacterial pathogens, particularly Pseudomonas aeruginosa and Staphylococcus aureus.

How can I schedule a meeting with Armata during the conference?

Interested individuals should contact their H.C. Wainwright representative to arrange one-on-one meetings with Armata Pharmaceuticals.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.